Molecular Surgeon Symposium on Genetics and Genomics of Pancreatic Cancer
分子外科医生胰腺癌遗传学和基因组学研讨会
基本信息
- 批准号:7408620
- 负责人:
- 金额:$ 0.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:AwardClinicalDataDiagnosisDisciplineFundingFutureGene Expression AlterationGene Expression RegulationGeneral PopulationGeneticGenomicsGoalsHousingInstitutionJournalsMalignant neoplasm of pancreasManuscriptsMedical StudentsMedical centerMedicineMolecularMucinsNeuropilinsOperative Surgical ProceduresParticipantPathogenesisPhysiciansPostdoctoral FellowPublicationsRAS genesRequest for ApplicationsResearchResearch PersonnelScientific Advances and AccomplishmentsScientistSeriesStudentsSurgeonTexasTimeTravelabstractinganticancer researchcollegeconceptcostdayinterestmembermesothelinmouse modelposterssymposium
项目摘要
DESCRIPTION (provided by applicant): This R13 application requests funds to partially (50%) support the Molecular Surgeon Symposium on Genetics and Genomics of Pancreatic Cancer, which will be the fourth time of the Molecular Surgeon Symposium series in the Baylor College of Medicine (BCM). The symposium will be held at the Texas Medical Center, Houston, Texas, on April 12 and 13, 2008. The overall goal of this interdisciplinary scientific symposium is to bring together scientists and physicians from diverse fields with a common interest in understanding Genetics and Genomics of Pancreatic Cancer. It will also provide a unique opportunity for trainees (postdoctoral fellows, clinical residents and fellows, medical students, and other scientists) to interact with investigators in the field of cancer research. This symposium is unique in that it will provide a forum for presenting and discussing the latest advances in pancreatic cancer research.
This one and a half day symposium will consist of an opening keynote presentation with the following scientific sessions: 1). Genomic alterations in pancreatic cancer; 2). Gene expression alteration in pancreatic cancer; 3). Gene regulation and functions in pancreatic cancer-I (mouse model and k-ras gene); and 4). Gene regulation and functions in pancreatic cancer-II (Smad, XIST, CACAM6, mucin, mesothelin, SSTR, neuropilins, and PDX-1). In addition, poster session will be organized.
Attendees will be invited to submit an abstract to poster section planned for the symposium that will allow all attendees, especially students, residents, and young investigators, to present their data and fully participate in discussions. We anticipate approximately 250 attendees. The limited attendance, focused scientific sessions, and highly successful poster session combined will provide an exciting forum for the exchange of ideas and will provide extensive opportunities for participation by a diverse group of scientists interested in pancreatic cancer. Funding is requested for planning and organizing the meeting and for travel and housing costs for speakers and those trainees selected for travel awards. Matching funds (50%) will be provided by the Institution to cover other costs. The Organizing/Scientific Committee will consist of members from research disciplines that represent the integrated/educational concept of the Symposium. At the conclusion of the symposium, participants should be able to: 1) understand the impact and opportunities of genetics and genomics on pancreatic cancer research; 2) discuss recent scientific advances related to molecular pathogenesis, diagnosis, and therapy for pancreatic cancer; 3) determine the future directions of pancreatic cancer research; and 4) establish a collaborative network in pancreatic cancer research. All presentations will be video-taped and presented on the "The Molecular Surgeon" website for general public access (website has been established since 1999). Furthermore, invited speakers are encouraged to submit manuscripts related to their presentations to "World Journal of Surgery" for consideration of publications.
描述(由申请人提供):此 R13 申请要求资金部分 (50%) 支持胰腺癌遗传学和基因组学分子外科医生研讨会,这将是贝勒医学院 (BCM) 分子外科医生系列研讨会的第四次。 该研讨会将于2008年4月12日至13日在德克萨斯州休斯敦的德克萨斯医学中心举行。这次跨学科科学研讨会的总体目标是将来自不同领域、对了解胰腺癌遗传学和基因组学有共同兴趣的科学家和医生聚集在一起。 它还将为学员(博士后研究员、临床住院医师和研究员、医学生和其他科学家)提供与癌症研究领域的研究人员互动的独特机会。 本次研讨会的独特之处在于它将提供一个展示和讨论胰腺癌研究最新进展的论坛。
这个为期一天半的研讨会将包括开幕主题演讲和以下科学会议:1)。胰腺癌的基因组改变; 2)。胰腺癌的基因表达改变; 3)。胰腺癌-I中的基因调控和功能(小鼠模型和k-ras基因);和 4)。胰腺癌 II 中的基因调控和功能(Smad、XIST、CACAM6、粘蛋白、间皮素、SSTR、神经毡蛋白和 PDX-1)。 此外,还将举办海报展示会。
将邀请与会者向研讨会计划的海报部分提交摘要,以便所有与会者,特别是学生、居民和年轻研究者,展示他们的数据并充分参与讨论。 我们预计约有 250 名与会者。 有限的出席人数、重点突出的科学会议和非常成功的海报会议相结合,将为思想交流提供一个令人兴奋的论坛,并将为对胰腺癌感兴趣的不同科学家群体提供广泛的参与机会。 需要资金来规划和组织会议以及演讲者和被选为获得旅行奖励的学员的旅行和住宿费用。 机构将提供配套资金(50%)来支付其他费用。 组织/科学委员会将由来自代表研讨会综合/教育概念的研究学科的成员组成。 研讨会结束时,与会者应该能够: 1)了解遗传学和基因组学对胰腺癌研究的影响和机遇; 2) 讨论与胰腺癌分子发病机制、诊断和治疗相关的最新科学进展; 3)确定胰腺癌研究的未来方向; 4) 建立胰腺癌研究合作网络。 所有演示都将被录像并发布在“分子外科医生”网站上供公众访问(该网站自 1999 年建立)。 此外,鼓励受邀演讲者将与他们的演讲相关的手稿提交给《世界外科杂志》以供考虑出版。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Improved diagnosis of pancreatic adenocarcinoma using haptoglobin and serum amyloid A in a panel screen.
- DOI:10.1007/s00268-008-9853-9
- 发表时间:2009-04
- 期刊:
- 影响因子:2.6
- 作者:Firpo, Matthew A.;Gay, David Z.;Granger, Steven R.;Scaife, Courtney L.;DiSario, James A.;Boucher, Kenneth M.;Mulvihill, Sean J.
- 通讯作者:Mulvihill, Sean J.
Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis.
- DOI:10.1007/s00268-008-9833-0
- 发表时间:2009-04
- 期刊:
- 影响因子:2.6
- 作者:Zhang, Yuqing;Li, Min;Wang, Hao;Fisher, William E.;Lin, Peter H.;Yao, Qizhi;Chen, Changyi
- 通讯作者:Chen, Changyi
MicroRNAs: control and loss of control in human physiology and disease.
- DOI:10.1007/s00268-008-9836-x
- 发表时间:2009-04
- 期刊:
- 影响因子:2.6
- 作者:Li, Min;Marin-Muller, Christian;Bharadwaj, Uddalak;Chow, Kwong-Hon;Yao, Qizhi;Chen, Changyi
- 通讯作者:Chen, Changyi
Current understanding and potential immunotherapy for HIV-associated squamous cell carcinoma of the anus (SCCA).
- DOI:10.1007/s00268-008-9835-y
- 发表时间:2009-04
- 期刊:
- 影响因子:2.6
- 作者:Marin-Muller, Christian;Li, Min;Chen, Changyi;Yao, Qizhi
- 通讯作者:Yao, Qizhi
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Changyi Chen其他文献
Changyi Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Changyi Chen', 18)}}的其他基金
Natural Substance Derivative DHNB is A Novel Xanthine Oxidase Inhibitor
天然物质衍生物DHNB是一种新型黄嘌呤氧化酶抑制剂
- 批准号:
8443691 - 财政年份:2013
- 资助金额:
$ 0.5万 - 项目类别:
Molecular Surgeon Research Training on Vascular Disease
分子外科医生血管疾病研究培训
- 批准号:
7343457 - 财政年份:2008
- 资助金额:
$ 0.5万 - 项目类别:
Molecular Surgeon Research Training on Vascular Disease
分子外科医生血管疾病研究培训
- 批准号:
8316269 - 财政年份:2008
- 资助金额:
$ 0.5万 - 项目类别:
Molecular Surgeon Research Training on Vascular Disease
分子外科医生血管疾病研究培训
- 批准号:
7902294 - 财政年份:2008
- 资助金额:
$ 0.5万 - 项目类别:
Molecular Surgeon Research Training on Vascular Disease
分子外科医生血管疾病研究培训
- 批准号:
7676707 - 财政年份:2008
- 资助金额:
$ 0.5万 - 项目类别:
Molecular Surgeon Research Training on Vascular Disease
分子外科医生血管疾病研究培训
- 批准号:
8132897 - 财政年份:2008
- 资助金额:
$ 0.5万 - 项目类别:
Molecular Surgeon Symposium on Vascular Injury, Repair
分子外科医生血管损伤、修复研讨会
- 批准号:
7057158 - 财政年份:2005
- 资助金额:
$ 0.5万 - 项目类别:
Effects of HAART drugs on endothelial dysfunction of pu*
HAART药物对pu*内皮功能障碍的影响
- 批准号:
7123488 - 财政年份:2005
- 资助金额:
$ 0.5万 - 项目类别:
Effects of HAART drugs on endothelial dysfunction of pu*
HAART药物对pu*内皮功能障碍的影响
- 批准号:
7250204 - 财政年份:2005
- 资助金额:
$ 0.5万 - 项目类别:
Effects of HAART drugs on endothelial dysfunction of pu*
HAART药物对pu*内皮功能障碍的影响
- 批准号:
7037236 - 财政年份:2005
- 资助金额:
$ 0.5万 - 项目类别:
相似国自然基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
EAGER: Integrating Pathological Image and Biomedical Text Data for Clinical Outcome Prediction
EAGER:整合病理图像和生物医学文本数据进行临床结果预测
- 批准号:
2412195 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Standard Grant
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Research Grant
Measurement and analysis of radiotherapy small field dosimetry data to support the development of a simulation training product for clinical Radiotherapy Physicists.
放射治疗小场剂量测定数据的测量和分析,以支持临床放射治疗物理学家模拟培训产品的开发。
- 批准号:
10089179 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Collaborative R&D
Archer: Next-generation unstructured data access for hospitals and clinical trial sponsors, delivering efficiency, reducing costs and improving care
Archer:为医院和临床试验申办者提供下一代非结构化数据访问,提高效率、降低成本并改善护理
- 批准号:
10096804 - 财政年份:2024
- 资助金额:
$ 0.5万 - 项目类别:
Collaborative R&D
Development and clinical application of AI model to support diagnosis of dementia using medical big data from electronic medical records
利用电子病历中的医疗大数据支持痴呆症诊断的人工智能模型的开发和临床应用
- 批准号:
22KJ3211 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Using clinical polysomnography data and machine learning to determine minimum sensing requirements for pediatric sleep studies
使用临床多导睡眠图数据和机器学习来确定儿科睡眠研究的最低传感要求
- 批准号:
491364 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Operating Grants
Pediatric Hospitals as European drivers for multi-party computation and synthetic data generation capabilities across clinical specialties and data types
儿科医院是欧洲跨临床专业和数据类型多方计算和合成数据生成能力的推动者
- 批准号:
10103799 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
EU-Funded
Developing Novel Technology for Data Driven Clinical Decision Making
开发数据驱动临床决策的新技术
- 批准号:
MR/Y007816/1 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Research Grant
Risk stratifying indeterminate pulmonary nodules with jointly learned features from longitudinal radiologic and clinical big data
利用纵向放射学和临床大数据共同学习的特征对不确定的肺结节进行风险分层
- 批准号:
10678264 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Generating Reproducible Real-World Evidence with Multi-Source Data to Capture Unstructured Clinical Endpoints for Chronic Diseases
利用多源数据生成可重复的真实世界证据,以捕获慢性病的非结构化临床终点
- 批准号:
10797849 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:














{{item.name}}会员




